Gilead’s Kite Pharma is doubling…
Gilead’s Kite Pharma is doubling down on in vivo CAR-T, [...]
The trials demonstrated the…
The trials demonstrated the benefits of Praxis’ ulixacaltamide in essential [...]
French antibody specialist…
French antibody specialist Adcytherix has added a €105 million ($122 [...]
Boehringer Ingelheim will pay…
Boehringer Ingelheim will pay AimedBio up to $991 million to [...]
Eli Lilly has guided its oral…
Eli Lilly has guided its oral GLP-1 drug candidate orforglipron [...]
After Omeros decided to hit pause…
After Omeros decided to hit pause on developing its MASP-3 [...]
BioCryst Pharmaceuticals has…
BioCryst Pharmaceuticals has struck a $700 million deal to buy [...]
Kailera Therapeutics has raised…
Kailera Therapeutics has raised $600 million to take its lead [...]
Denali Therapeutics has become the…
Denali Therapeutics has become the latest on a growing list [...]
The California biotech is…
The California biotech is developing a new drug class in [...]